Literature DB >> 32411498

G protein-coupled receptor 68 increases the number of B lymphocytes.

Xiaofei He1, Saran Feng1, Caleb Hawkins1, Lauren Lawley1, Wenxin Fan1, Yan Xu2, Xiang-Ming Zha3, Jing Fang1.   

Abstract

G protein-coupled receptor 68 (GPR68) is a proton sensor that is activated upon binding to extracellular protons. We have previously found that GPR68 induces a proapoptotic pathway in bone marrow (BM) cells from the patients with myelodysplastic syndromes (MDS) after treated with lenalidomide. However, the function of GPR68 in normal hematopoietic cells remains unclear. With genetic loss of function approach, we found reduced frequency and number of B lymphocytes in the peripheral blood (PB) of whole body Gpr68-/- mice compared to control littermates upon aging. During hematopoietic regeneration, such as in response to fluorouracil (5-FU), we also found reduced frequency and number of B lymphocytes in Gpr68-/- mice compared to wild type mice. Mechanism studies revealed that Gpr68 expression was upregulated in B lymphocytes of BM during aging and in hematopoietic progenitor cells after treatment with 5-FU. In addition, activation of Gpr68 by its activators increased the frequency and number of B lymphocytes. Our studies indicate that Gpr68 expression is upregulated in hematopoietic cells upon aging and during hematopoietic regeneration that ends up with increased number of B lymphocytes. AJBR
Copyright © 2020.

Entities:  

Keywords:  G protein-coupled receptors; GPR68 agonist; GPR68 allosteric modulator; hematologic regeneration; hematopoiesis; stress hematopoiesis

Year:  2020        PMID: 32411498      PMCID: PMC7218682     

Source DB:  PubMed          Journal:  Am J Blood Res        ISSN: 2160-1992


  17 in total

Review 1.  Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond.

Authors:  Chetasi Talati; David Sallman; Alan List
Journal:  Semin Hematol       Date:  2017-06-22       Impact factor: 3.851

2.  GPR68 Senses Flow and Is Essential for Vascular Physiology.

Authors:  Jie Xu; Jayanti Mathur; Emilie Vessières; Scott Hammack; Keiko Nonomura; Julie Favre; Linda Grimaud; Matt Petrus; Allain Francisco; Jingyuan Li; Van Lee; Fu-Li Xiang; James K Mainquist; Stuart M Cahalan; Anthony P Orth; John R Walker; Shang Ma; Viktor Lukacs; Laura Bordone; Michael Bandell; Bryan Laffitte; Yan Xu; Shu Chien; Daniel Henrion; Ardem Patapoutian
Journal:  Cell       Date:  2018-04-19       Impact factor: 41.582

3.  Regulated expression of pH sensing G Protein-coupled receptor-68 identified through chemical biology defines a new drug target for ischemic heart disease.

Authors:  Jamie L Russell; Sean C Goetsch; Hector R Aguilar; Helen Coe; Xiang Luo; Ning Liu; Eva van Rooij; Doug E Frantz; Jay W Schneider
Journal:  ACS Chem Biol       Date:  2012-05-09       Impact factor: 5.100

4.  The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche.

Authors:  Tugba Simsek; Fatih Kocabas; Junke Zheng; Ralph J Deberardinis; Ahmed I Mahmoud; Eric N Olson; Jay W Schneider; Cheng Cheng Zhang; Hesham A Sadek
Journal:  Cell Stem Cell       Date:  2010-09-03       Impact factor: 24.633

5.  A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromes.

Authors:  Jing Fang; Xiaona Liu; Lyndsey Bolanos; Brenden Barker; Carmela Rigolino; Agostino Cortelezzi; Esther N Oliva; Maria Cuzzola; H Leighton Grimes; Celia Fontanillo; Kakajan Komurov; Kyle MacBeth; Daniel T Starczynowski
Journal:  Nat Med       Date:  2016-06-13       Impact factor: 53.440

6.  Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65.

Authors:  Xi-Ping Huang; Joel Karpiak; Wesley K Kroeze; Hu Zhu; Xin Chen; Sheryl S Moy; Kara A Saddoris; Viktoriya D Nikolova; Martilias S Farrell; Sheng Wang; Thomas J Mangano; Deepak A Deshpande; Alice Jiang; Raymond B Penn; Jian Jin; Beverly H Koller; Terry Kenakin; Brian K Shoichet; Bryan L Roth
Journal:  Nature       Date:  2015-11-09       Impact factor: 49.962

7.  The transcription factor Foxm1 is essential for the quiescence and maintenance of hematopoietic stem cells.

Authors:  Yu Hou; Wen Li; Yue Sheng; Liping Li; Yong Huang; Zhonghui Zhang; Tongyu Zhu; David Peace; John G Quigley; Wenshu Wu; You-Yang Zhao; Zhijian Qian
Journal:  Nat Immunol       Date:  2015-06-29       Impact factor: 25.606

8.  Treatment of patients with multiple myeloma progressing on frontline-therapy with lenalidomide.

Authors:  Philippe Moreau; Elena Zamagni; Maria-Victoria Mateos
Journal:  Blood Cancer J       Date:  2019-03-20       Impact factor: 11.037

Review 9.  Acidic tumor microenvironment and pH-sensing G protein-coupled receptors.

Authors:  Calvin R Justus; Lixue Dong; Li V Yang
Journal:  Front Physiol       Date:  2013-12-05       Impact factor: 4.566

10.  OGR1/GPR68 Modulates the Severity of Experimental Autoimmune Encephalomyelitis and Regulates Nitric Oxide Production by Macrophages.

Authors:  Cheryl A D'Souza; Fei Linda Zhao; Xujian Li; Yan Xu; Shannon E Dunn; Li Zhang
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

View more
  2 in total

1.  Differential Roles of Extracellular Histidine Residues of GPR68 for Proton-Sensing and Allosteric Modulation by Divalent Metal Ions.

Authors:  Xi-Ping Huang; Terrence P Kenakin; Shuo Gu; Brian K Shoichet; Bryan L Roth
Journal:  Biochemistry       Date:  2020-09-10       Impact factor: 3.162

2.  Whole body deletion of Gpr68 does not change hematopoietic stem cell function.

Authors:  Xiaofei He; Caleb Hawkins; Lauren Lawley; Kennedy Freeman; Tra Mi Phan; Jiajia Zhang; Yan Xu; Jing Fang
Journal:  Stem Cell Res       Date:  2020-06-20       Impact factor: 2.020

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.